Tuesday, February 24, 2004


GLUCOPHAGE (metformin hydrochloride tablets)
GLUCOPHAGE XR (metformin hydrochloride
extended-release tablets)
Oral Antidiabetes Medications (FDA Consumer magazine, January-February 2002)

Wednesday, February 18, 2004

Thursday, February 12, 2004

Diabetes and Macrovascular Disease: Risk Factor Management
The Impact of Cardiovascular Disease
What We Know About the Endothelium
Vasculoprotection With Nitric Oxide
The Role of Oxidative Stress in Endothelial Dysfunction and Vascular Disease
The Renin-Angiotensin System: A Major Role in Endothelial Function
Putting It All Together: The Path to Coronary Artery Disease
Endothelial Dysfunction: Causes and Treatment Strategies
Plaque Pathology: An Inside View
Diabetes: A Source of Endothelial Insult
Reducing Macrovascular Complications: Evidence From the Statin Trials
More on the Vasculoprotective Effects of Lipid Lowering With Statins
Reducing Macrovascular Complications: Evidence From the Angiotensin-Converting Enzyme Inhibitor Trials
Findings From the Heart Outcomes Prevention Evaluation
Vasculoprotection With Angiotensin-Converting Enzyme Inhibitors
The Current Views on Risk Reduction Therapy


Wednesday, February 11, 2004

Cross-Talk Between Iron Metabolism and Diabetes
Emerging scientific evidence has disclosed unsuspected influences between iron metabolism and type 2 diabetes. The relationship is bi-directional—iron affects glucose metabolism, and glucose metabolism impinges on several iron metabolic pathways. Oxidative stress and inflammatory cytokines influence these relationships, amplifying and potentiating the initiated events. The clinical impact of these interactions depends on both the genetic predisposition and the time frame in which this network of closely related signals acts
Iron Stores in Healthy Women Linked to Diabetes Risk

Feb. 10, 2004 — Higher amounts of iron stores in the blood are associated with an increased risk of type 2 diabetes in healthy women with no known diabetes risk factors, according to the results of a nested case-control trial published in the Feb. 11 issue of The Journal of the American Medical Association.

Tuesday, February 03, 2004

Diabetes Care: Small-Bowel Bacterial Overgrowth in Diabetic Subjects Is Associated With Cardiovascular Autonomic Neuropathy.: "Gastrointestinal symptoms are present in 50-70% of patients with diabetes. Delayed gastric emptying, and disturbance of intestinal motility are frequent findings [1,2]. Impaired intestinal motility is often followed by small-bowel bacterial overgrowth (SBBO), which can possibly lead to deconjugation of bile acids, diarrhea, "

Monday, February 02, 2004

Medscape Resource Center - Diabetic Microvascular Complications: "Diabetes is, of course, a disease of complications. But landmark studies such as the Diabetes Control and Complication Trial have shown that achieving tight glycemic control can directly reduce the risk of diabetic complications, especially diabetic microvascular complications. New screening tools and potential new treatments also hold promise for making diabetic microvascular complications such as retinopathy and neuropathy more manageable and less inevitable."

Monday, January 26, 2004

Laxity in Diabetic Care in the US - MedicineNet.com Medical References for Patients

Quote: "If you're a diabetic over 55, you should be on an aspirin a day, a lipid-lowering agent [to lower cholesterol], and a medication to prevent heart attacks, like an ACE inhibitor. Heart attacks kill 80% of diabetics, and you can drop that by 70% by taking those three medications. You should therefore see your provider and discuss getting on them. Simple three pills, very safe and very simple, with almost no side effects. It could add years to your life." (Dr. R. James Dudi, Kaiser Permanente Health Plan, San Diego)

Wednesday, January 21, 2004

BBC NEWS | Health | Back pain drug 'may aid diabetics'

A drug used to treat backpain may also prevent patients with diabetes from going blind or having limbs amputated, a study suggests.
Scientists in the United States have found evidence to indicate that benfotiamine may be able to keep blood vessels healthy.

Saturday, January 03, 2004

The Five Absolute Worst Foods You Can Eat 10/18/03

By Dr. Joseph Mercola
with Rachael Droege


There are no “bad” foods, right? Only food you should eat in moderation? Well, not really. The following foods are so bad for your body that I really can’t see any reason to eat them. Not only do they have zero nutritional value, but they also give your body a healthy dose of toxins, which should make the idea of eating them really hard to swallow.

Monday, December 29, 2003

Joslin Diabetes Center - Diabetes, Diabetes Treatment, Diabetes Symptom, Diabetes Research and Diabetes Education.

Joslin Clinic and Beth Israel Deaconess Medical Center (BIDMC) are collaborating to provide our patients the most comprehensive spectrum of multidisciplinary diabetes care in the outpatient and inpatient setting available anywhere.

Friday, December 26, 2003

Yahoo! News - EATING TO LIVE
According to "SuperFoods Rx: Fourteen Foods That Will Change Your Life" (William Morrow, $24.95), some foods will not only improve your life - but may well extend it.

Tuesday, December 23, 2003

NutritionData's Nutrition Facts Calorie Counter: "NutritionData

Nutrition Facts Calorie Counter

NutritionData (ND) generates nutrition facts labels and provides simplified nutritional analyses for all foods and recipes.

ND tells you what's good and bad about the foods you eat, and helps you select foods that best meet your dietary needs."

Friday, December 19, 2003

Wednesday, December 17, 2003

Triple Therapy Better Than Mixed Insulin for Obese Type 2 DM

Dec. 5, 2003 — Combining rosiglitazone, metformin, and insulin aspart improved glucose metabolism in obese type 2 diabetic patients compared with mixed insulin alone, according to the results of a open-label, randomized trial published in the December issue of Diabetes Care

READ
ASHP Therapeutic Position Statement on Strict Glycemic Control: "The American Society of Health-System Pharmacists (ASHP) supports strict glycemic control in all appropriate patients with diabetes mellitus. Strict glycemic control in patients with type 1 and type 2 diabetes mellitus has been shown to reduce the progression of some of the disease's chronic complications, including nephropathy, retinopathy, and neuropathy, and there are strong indications that such control may reduce the risks associated with macrovascular disease"